LKFT · Lakefront Biotherapeutics NV · Share Buybacks
$33.49
+0.10 (+0.30%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q1 2026 earnings call transcript
Market Cap
$2.20B
Shares
65.90M
Volume · Nov 20
38.91K
Avg daily vol (3M)
281.53K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-11-11 | 50,000,000 EUR | — | — | — | Press release , published 2026-11-11 |
Key facts
CIK
1421876
CUSIP
36315X101
13F (30d)
109 filings
93 filers
Visit website
Investor relations